Stay informed on the latest beverage industry regulatory updates involving the Federal Trade Commission (FTC), Food and Drug Administration (FDA), or United States Department of Agriculture(USDA), as well as news regarding lawsuits, labeling and class-actions. Understand the evolving beverage regulatory and legal environment which can directly impact your product claims, intellectual property, packaging and ingredients.
Hemp beverages may have earned a temporary reprieve from upcoming federal restrictions after the U.S. Senate passed a continuing budget resolution over the weekend that extends the deadline until December 11.
U.S. Congressman Andy Barr (R-KY) introduced a long-awaited hemp legalization bill today, seeking to create a comprehensive regulatory framework for hemp-derived consumer products ahead of the looming November ban.
Hemp industry advocates are celebrating the inclusion of pro-hemp language in a recent White House letter to Congress.
A pair of class action lawsuits filed in California last week accuse two well-known beverage companies of making false and misleading claims on their packaging and in marketing materials.
Blue Diamond reported to be settling class action lawsuit for about $9 million, Justin Timberlake is set to star in Bai's upcoming Super Bowl commercial, and the FDA cracks down on alleged camel milk "miracle cure."
In a move that some experts have described as similar in strategy to the legal actions taken against the tobacco industry in the 1990s, a new lawsuit accuses Coke and CSD-friendly trade group American Beverage Association (ABA) of engaging in a 40-year “elaborate campaign of disinformation” to minimize the health risks associated with soft drink consumption.
As the last year ended, a group of 32 U.S. congressmen threw those drinks a holiday-season curveball in the form of a letter that argued so-called “alt-milks” aren’t “milk” at all, and pressured the FDA to take action to reserve that descriptor for dairy products only.
The draft guidance, a series of recommendations addressing issues ranging from manufacturer compliance and the declaration of added sugars to appropriate spacing between lines on the label itself, is an in-progress version of guidelines that will represent the current thinking of the FDA when finalized.
